HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Pierce Selected Research

Tumor Suppressor Proteins (Proteins, Tumor Suppressor)

10/2016O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Pierce Research Topics

Disease

18Neoplasms (Cancer)
03/2021 - 07/2002
7Breast Neoplasms (Breast Cancer)
03/2021 - 07/2007
6Carcinoma (Carcinomatosis)
03/2021 - 03/2005
5Carcinogenesis
10/2017 - 12/2002
4Infections
10/2022 - 05/2002
3Ovarian Neoplasms (Ovarian Cancer)
03/2021 - 08/2008
3Fibrosarcoma
12/2009 - 12/2002
2Colonic Neoplasms (Colon Cancer)
10/2017 - 11/2014
2Adenoma (Adenomas)
11/2014 - 02/2010
2Neuroblastoma
11/2008 - 09/2006
1Foodborne Diseases
02/2024
1Bacterial Infections (Bacterial Infection)
11/2023
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2021
1Stomach Neoplasms (Stomach Cancer)
10/2016
1Disease Progression
05/2010
1Adenocarcinoma
02/2010
1Muscular Dystrophies (Muscular Dystrophy)
09/2006
1Prostatic Neoplasms (Prostate Cancer)
01/2006
1Choriocarcinoma
03/2005
1Parasitic Diseases (Parasitic Disease)
08/2004
1Colorectal Neoplasms (Colorectal Cancer)
11/2003

Drug/Important Bio-Agent (IBA)

13Polysaccharides (Glycans)IBA
10/2016 - 12/2003
8Proteins (Proteins, Gene)FDA Link
03/2021 - 10/2002
6LectinsIBA
02/2010 - 01/2004
5Glycoproteins (Glycoprotein)IBA
11/2014 - 03/2005
5Biomarkers (Surrogate Marker)IBA
01/2014 - 04/2008
4Small Interfering RNA (siRNA)IBA
03/2021 - 07/2007
4Cadherins (E-Cadherin)IBA
10/2016 - 11/2003
4EnzymesIBA
01/2014 - 07/2002
4GlycosyltransferasesIBA
02/2010 - 09/2006
4alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA
12/2009 - 12/2002
2eravacyclineIBA
11/2023 - 10/2022
2Tetracycline (Achromycin)FDA LinkGeneric
10/2022 - 12/2002
2Transcription Factors (Transcription Factor)IBA
03/2021 - 10/2002
2Messenger RNA (mRNA)IBA
03/2021 - 08/2004
2GPI-Linked ProteinsIBA
01/2014 - 07/2012
2Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
01/2014 - 07/2012
2Epidermal Growth Factor (EGF)IBA
05/2009 - 07/2007
2IntegrinsIBA
09/2006 - 12/2002
1Shiga Toxins (Vero Toxin)IBA
02/2024
1RicinIBA
02/2024
1Carbapenems (Carbapenem Antibiotics)IBA
10/2022
1MicroRNAs (MicroRNA)IBA
03/2021
1RNA (Ribonucleic Acid)IBA
10/2017
1AcetylglucosamineIBA
10/2017
1hexosaminidase CIBA
10/2017
1UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA
10/2017
1SuspensionsIBA
10/2017
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
10/2016
1COOH-terminal signal transamidaseIBA
01/2014
1Carcinoembryonic AntigenIBA
01/2014
1MesothelinIBA
01/2014
1Membrane Proteins (Integral Membrane Proteins)IBA
07/2012
1PeriostinIBA
02/2010
1ThrombospondinsIBA
02/2010
1ErbB Receptors (EGF Receptor)IBA
05/2009
1LigandsIBA
05/2009
1Class 5 Receptor-Like Protein Tyrosine PhosphatasesIBA
11/2008
1N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase)IBA
04/2008
1Focal Adhesion Protein-Tyrosine KinasesIBA
07/2007
1protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA
09/2006
1Laminin (Merosin)IBA
09/2006
1perlecanIBA
01/2006
1Hormones (Hormone)IBA
03/2005
1Immunoglobulin FragmentsIBA
03/2005
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
03/2005
1GonadotropinsIBA
03/2005
1CarbohydratesIBA
03/2005
1Tumor Viral Antigens (Large T Antigen)IBA
03/2005
1Oncogene Proteins (Oncogene Protein)IBA
03/2005
1ProteomeIBA
08/2004
1Amino AcidsFDA Link
08/2004
1beta CateninIBA
11/2003
1Peptides (Polypeptides)IBA
06/2003
1OligosaccharidesIBA
12/2002

Therapy/Procedure

3Therapeutics
10/2022 - 01/2006
1Highly Active Antiretroviral Therapy (HAART)
05/2002